A Phase 1, Bio-equivalence Study of TAK-536 Pediatric Formulation

Clinical trial NCT03042299 · COMPLETED

Trial details

NCT number: NCT03042299
Sponsor: Takeda
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Japanese Healthy Adult Male Participants

Start date: 2017-02-10
Primary completion: 2017-03-11
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.